A Shared Decision Making Training for Inpatients With Schizophrenia

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2010 by Technische Universität München.
Recruitment status was  Recruiting
The German-Israeli Foundation for Scientific Research and Development
Information provided by:
Technische Universität München
ClinicalTrials.gov Identifier:
First received: April 20, 2009
Last updated: April 7, 2010
Last verified: April 2010
Patients suffering from schizophrenia who attend the communication skills program engage more deeply in therapeutic reasoning and treatment decisions. This results in stronger preferences to participate, greater perceived involvement and better long term adherence compared to patients who do not attend the training.

Condition Intervention
Schizoaffective Disorder
Behavioral: patient training in shared decision making
Behavioral: cognitive training

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Shared Decision Making: Ein Kommunikationstraining für Patienten Mit Schizophrenie

Resource links provided by NLM:

Further study details as provided by Technische Universität München:

Primary Outcome Measures:
  • Decision Self Efficacy [ Time Frame: post intervention ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Adherence to medication [ Time Frame: 6 months post intervention ] [ Designated as safety issue: No ]
  • Participation preferences [ Time Frame: post intervention ] [ Designated as safety issue: No ]
  • Treatment satisfaction [ Time Frame: post intervention ] [ Designated as safety issue: No ]

Estimated Enrollment: 80
Study Start Date: May 2009
Arms Assigned Interventions
Experimental: communication skills training
group training in shared decision making.
Behavioral: patient training in shared decision making
Active Comparator: cognitive training
standard group training of cognitive skills (Konzentrationstraining)
Behavioral: cognitive training


Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Male and female inpatients with a diagnosis of schizophrenia/schizoaffective disorder according to ICD 10
  • between 18 and 60 years of age are eligible for the study
  • informed consent
  • inpatients

Exclusion Criteria:

  • poor German language skills
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00885716

Contact: Johannes Hamann, MD +49894140 ext 4282 j.hamann@lrz.tum.de

Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Recruiting
München, Germany
Sub-Investigator: Werner Kissling, MD         
Principal Investigator: Johannes Hamann, MD         
Sponsors and Collaborators
Technische Universität München
The German-Israeli Foundation for Scientific Research and Development
  More Information

No publications provided by Technische Universität München

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: PD Dr. Johannes Hamann, Technische universität München
ClinicalTrials.gov Identifier: NCT00885716     History of Changes
Other Study ID Numbers: GIF2168-1764.1 
Study First Received: April 20, 2009
Last Updated: April 7, 2010
Health Authority: Germany: Federal Ministry of Education and Research

Additional relevant MeSH terms:
Psychotic Disorders
Mental Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on February 11, 2016